Detalhe da pesquisa
1.
Disruption of the circadian clock component BMAL1 elicits an endocrine adaption impacting on insulin sensitivity and liver disease.
Proc Natl Acad Sci U S A
; 119(10): e2200083119, 2022 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35238641
2.
Validation of the new 2021 EASL algorithm for the noninvasive diagnosis of advanced fibrosis in NAFLD.
Hepatology
; 77(3): 920-930, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35822302
3.
High prevalence of diabetes among young First Nations Peoples with metabolic dysfunction-associated steatotic liver disease: a population-based study in Australia.
Int J Equity Health
; 23(1): 84, 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38689295
4.
Serum CC-Chemokine Ligand 2 Is Associated with Visceral Adiposity but Not Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.
Dig Dis
; 41(3): 439-446, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36327947
5.
Diabetes mellitus and the progression of non-alcoholic fatty liver disease to decompensated cirrhosis: a retrospective cohort study.
Med J Aust
; 219(8): 358-365, 2023 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37749902
6.
Differences in the pattern and cost of hospital care between Indigenous and non-Indigenous Australians with cirrhosis: an exploratory study.
Intern Med J
; 53(6): 961-969, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35717648
7.
Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonists.
Ann Hepatol
; 28(6): 101142, 2023 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37468097
8.
A discrete choice experiment to elicit preferences for a liver screening programme in Queensland, Australia: a mixed methods study to select attributes and levels.
BMC Health Serv Res
; 23(1): 950, 2023 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37670274
9.
Partnering with support persons and clinicians to improve the health care experiences of patients with cirrhosis.
J Clin Nurs
; 32(11-12): 2559-2574, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35451073
10.
Complexity of ballooned hepatocyte feature recognition: Defining a training atlas for artificial intelligence-based imaging in NAFLD.
J Hepatol
; 76(5): 1030-1041, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35090960
11.
Non-alcoholic fatty liver disease.
Lancet
; 397(10290): 2212-2224, 2021 06 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33894145
12.
An exploration of barriers and facilitators to implementing a nonalcoholic fatty liver disease pathway for people with type 2 diabetes in primary care.
Diabet Med
; 39(6): e14799, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35100462
13.
Poor disease knowledge is associated with higher healthcare service use and costs among patients with cirrhosis: an exploratory study.
BMC Gastroenterol
; 22(1): 340, 2022 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35836105
14.
Towards collaborative management of non-alcoholic fatty liver disease: a 'real-world' pathway for fibrosis risk assessment in primary care.
Intern Med J
; 52(10): 1749-1758, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34139066
15.
Implementing the right care in the right place at the right time for non-alcoholic fatty liver disease (NAFLD-RRR study): a study protocol for a community care pathway for people with type 2 diabetes.
BMC Health Serv Res
; 22(1): 487, 2022 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35413987
16.
Stereotactic radiotherapy for hepatocellular carcinoma: Expanding the multidisciplinary armamentarium.
J Gastroenterol Hepatol
; 36(4): 873-884, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32632941
17.
Changing prevalence of aetiological factors and comorbidities among Australians hospitalised for cirrhosis.
Intern Med J
; 51(5): 691-698, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32096890
18.
Hospitalisation for cirrhosis in Australia: disparities in presentation and outcomes for Indigenous Australians.
Int J Equity Health
; 19(1): 27, 2020 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32066438
19.
Effectiveness of patient-oriented education and medication management intervention in people with decompensated cirrhosis.
Intern Med J
; 50(9): 1142-1146, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32929822
20.
Protocol for a randomised trial testing a community fibrosis assessment service for patients with suspected non-alcoholic fatty liver disease: LOCal assessment and triage evaluation of non-alcoholic fatty liver disease (LOCATE-NAFLD).
BMC Health Serv Res
; 20(1): 335, 2020 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32316984